Drug Pipeline

ZG005 for Injection Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
7
Active Studies
6
Recruiting
1
Top Sponsors
Active Studies by Phase
Phase 2
2
Phase 1/2
5
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07099547 Study of ZG005 in Combination With Platinum-Based Chemotherapy in Participants With… Biliary Tract Carcinoma Recruiting
NCT06927687 Study of ZG005 in Patients With Advanced Solid Tumors Advanced Solid Tumor Active, Not Recruiting
Phase 1/2
NCT06883526 Study of ZG005 in Combination With Gecacitinib in Patients With Relapsed or Refractory… Lymphoma Recruiting
NCT06903377 Study of ZG005 Combined With Gecacitinib in Patients With Advanced Non-Small Cell Lung… Non-small Cell Lung Cancer Recruiting
NCT06938880 Study of ZGGS18 in Combination With ZG005 in Patients With Advanced Solid Tumors Advanced Solid Tumor Recruiting
NCT07038096 ZG006 and ZG005 in Participants With Small Cell Lung Cancer or Neuroendocrine Carcinoma Small Cell Lung Cancer Recruiting
NCT07080216 Study of ZG005 in Combination With Gecacitinib in Participants With Advanced Cervical… Cervical Cancer Recruiting
Sponsors Running ZG005 for Injection Trials
Disease Areas
Get alerts when ZG005 for Injection trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free